# Quantoom Biosciences

> Quantoom Biosciences is a full-stack RNA partner for mRNA- and saRNA-based vaccines and therapeutics. The N-Force toolbox covers RNA design (Ncode), RNA production (Ntensify®), and RNA-CNP formulation (Ncapsulate® QCX).

Quantoom Biosciences helps partners accelerate and de-risk RNA drug development from design to delivery, with technologies scalable from R&D to commercial production.

## Core pages

- [Quantoom Biosciences | the first end-to-end unified RNA platform](https://quantoom.com/): Quantoom Biosciences is a full-stack RNA partner for mRNA- and saRNA-based vaccines and therapeutics. Its N-Force toolbox spans sequence design (Ncode), scalable RNA production (Ntensify®), and RNA-CNP formulation (Ncapsulate® QCX), supporting partners from R&D through clinical supply.
- [Ntensify® RNA Production](https://quantoom.com/ntensify-mrna-production-solution/): Ntensify® is Quantoom's construct-agnostic mRNA and saRNA production solution. It combines an intensified in vitro transcription process, ready-to-use reagent mixes, scale-less disposables, and automated equipment—from bench kits to GMP systems—to compress timelines and cost from R&D to commercial supply.
- [Ncode — RNA design platform](https://quantoom.com/rna-sequence-design/): Ncode is the RNA design pillar of Quantoom's N-Force platform. It pairs a computational engine with expert bioinformaticians to convert antigenic information into RNA constructs optimized for expression, stability, and manufacturability—beyond standard codon optimization.
- [Ncapsulate® QCX — RNA formulation](https://quantoom.com/mrna-formulation/): Ncapsulate® QCX is Quantoom's proprietary class of lipid-like formulation chemistries for mRNA and saRNA delivery. Free of third-party IP, QCX chemistries feature adaptable heads and interchangeable tails, with a demonstrated track record in RNA-LLP formulation across vaccine and therapeutic programs.
- [Technical specifications Ntensify midi flex • Quantoom Biosciences](https://quantoom.com/resource/fact-sheet-ntensify-midi/): Quantoom Biosciences
- [Ntensify® mano — All-in-one RNA production & purification kit](https://quantoom.com/ntensify-mrna-production-solution/mrna-production-kit/): The Ntensify® mano is an all-in-one, cost-effective mRNA and saRNA production and purification kit. Using standard laboratory equipment, it delivers up to 3 mg of purified RNA in less than half a day—ideal for early R&D and proof-of-concept work on the Ntensify® process.
- [Ntensify® micro — Bench scale mRNA production system](https://quantoom.com/ntensify-mrna-production-solution/ntensify-micro-mrna-production-system/): The Ntensify® micro is the most compact automated system for the Ntensify® process. It produces and purifies 0.4 mg to 160 mg of high-quality mRNA in 3 hours, with a GMP-compatible scale-down path to the Ntensify® midi flex for seamless process transfer.
- [Ntensify® midi flex — GMP RNA production system](https://quantoom.com/ntensify-mrna-production-solution/ntensify-midi-mrna-production-system/): The Ntensify® midi flex is a GMP-grade RNA production system synthesizing and purifying 0.1–8 g of RNA per batch using the same Ntensify® process as R&D systems. Designed for clinical and commercial supply, it supports capacity up to approximately 35 million doses per year.
- [Ntensify® mini — mRNA production system](https://quantoom.com/ntensify-mrna-production-solution/ntensify-mini-mrna-production-system/): The Ntensify® mini is a research-grade RNA production system that automates synthesis and purification on the Ntensify® platform. It supports up to 48 constructs at 2 mg scale or a single construct at 100 mg scale—suited to multi-construct screening and preclinical supply.
- [TAMARA RNA-LNP Formulation Platform](https://quantoom.com/tamara/): TAMARA is an RNA-LLP formulation platform for R&D developed with Inside Therapeutics. One system covers 0.2 mL screening to 30 mL preclinical batches using reusable microfluidic chips, with greater than 90% RNA recovery—accelerating lipid-like particle formulation development.
- [N-Force R&D Services](https://quantoom.com/services/): Quantoom's N-Force R&D services span the full RNA stack: end-to-end R&D and development partnerships, custom lipid-like particle (LLP) formulation, and GMP production for clinical programs. Partners collaborate with Quantoom from sequence design through formulated drug product.
- [About us — Your full-stack RNA partner](https://quantoom.com/about-us/): Quantoom Biosciences is a Belgian biotech headquartered in Nivelles, industrialising mRNA and saRNA production. The company develops the N-Force toolbox to make RNA vaccines and therapeutics more affordable and accessible worldwide.
- [Applications](https://quantoom.com/applications/): Quantoom applies its N-Force RNA toolbox across therapeutic areas including animal health, infectious disease, and oncology—supporting programs from antigen design through production and LLP formulation.
- [Animal Health — RNA vaccines for veterinary applications](https://quantoom.com/applications/animal-health/): Quantoom supports RNA-based veterinary vaccines with saRNA affordability, validated HPAI programs, Ncode bioinformatics, Ncapsulate® QCX delivery, and Ntensify® midi flex manufacturing—plus R&D partnerships for animal health innovators.
- [Infectious Disease — Prophylactic (sa)mRNA vaccines](https://quantoom.com/applications/infectious-disease/): Quantoom's N-Force toolbox supports prophylactic mRNA and saRNA vaccine programs for infectious disease—from sequence design and production to LLP formulation—helping partners prepare for epidemic and pandemic threats.
- [Personalized Cancer Therapies — Cancer vaccine programs](https://quantoom.com/applications/oncology/): Quantoom partners on cancer vaccine programs using shared-antigen and personalized neoantigen approaches—combining Ncode sequence design, Ntensify® RNA production, and Ncapsulate® QCX formulation for oncology R&D and clinical development.
- [Our Partners](https://quantoom.com/our-partners/): Quantoom's international distributor network supplies Ntensify® equipment and reagents globally. Find a regional distributor or apply to become an official Quantoom Biosciences distributor.
- [Resources](https://quantoom.com/resources/): Quantoom's resource library includes brochures, fact sheets, technical notes, and application data for the N-Force toolbox—covering Ncode RNA design, Ntensify® production systems, and Ncapsulate® QCX formulation.
- [Virtual showroom — Ntensify® midi flex](https://quantoom.com/virtual-showroom/): Explore the Ntensify® midi flex GMP RNA production system in an interactive 3D virtual showroom—covering upstream and downstream process steps, scale-less design, and commercial manufacturing benefits.
- [Book a call](https://quantoom.com/book-a-call/): Book a meeting with a Quantoom business developer to explore the Ntensify® product range and formulation services. Select your region to connect with the representative nearest to you.
- [CoA Mixes • Quantoom Biosciences](https://quantoom.com/coa-sds-mixes/): Download Certificates of Analysis (CoA) by lot number or Safety Data Sheets (SDS) by product reference for Ntensify® reagent mixes.
- [Company culture • Quantoom Biosciences](https://quantoom.com/company-culture/): Discover Quantoom Biosciences company culture—our commitment to inclusivity, diversity, and respect for individual differences at our Nivelles headquarters and across the team building the N-Force RNA platform.
- [Contact us](https://quantoom.com/contact-us/): Contact Quantoom Biosciences for commercial inquiries, R&D partnerships, media and press requests, or general questions about the N-Force RNA platform and Ntensify® product range.
- [Cookies notice](https://quantoom.com/cookies-notice/): Quantoom Biosciences cookies notice describing cookie categories, purposes, and how visitors can manage cookie preferences on quantoom.com.
- [Customer service](https://quantoom.com/customer-service/): Quantoom customer service and maintenance support for Ntensify® and Ncapsulate® systems, reagents, and disposables. Submit a support request for installation, training, or technical assistance.
- [/distributors-toolbox/](https://quantoom.com/distributors-toolbox/): Internal resources hub for authorised Quantoom distributors—sales tools, product information, and support materials for the Ntensify® range.
- [General Terms & Conditions of Sale](https://quantoom.com/general-terms-and-conditions-of-sale/): General terms and conditions of sale for Quantoom Biosciences (Phoenix Biosciences SA) products and services, including Ntensify® equipment, reagents, and related offerings.
- [Job applications • Quantoom Biosciences](https://quantoom.com/job-application/): Explore open positions at Quantoom Biosciences and apply online. Join the team developing Ncode, Ntensify®, and Ncapsulate® QCX to advance mRNA and saRNA vaccines and therapeutics.
- [Newsletter • Quantoom Biosciences](https://quantoom.com/newsletter/): Subscribe to the Quantoom Biosciences newsletter for company updates, product news, and insights on mRNA and saRNA design, production, and formulation.
- [/ntensify-micro-documentation/](https://quantoom.com/ntensify-micro-documentation/): Ntensify® micro user documentation and technical resources for the bench-scale mRNA production system.
- [Privacy statement](https://quantoom.com/privacy-statement/): Quantoom Biosciences (Phoenix Biosciences SA) privacy statement explaining how personal data is processed and the rights available under GDPR and applicable privacy laws.
- [/qr-code-box_redirection/](https://quantoom.com/qr-code-box_redirection/): Ntensify® mano user guides and troubleshooting documentation—download resources for the all-in-one RNA production kit via Quantoom's QR resource hub.
- [/qr-code-qcx/](https://quantoom.com/qr-code-qcx/): Ncapsulate® QCX formulation resources and documentation available for download from Quantoom's QR-linked resource page.
- [Recruitment privacy statement](https://quantoom.com/recruitment-privacy-statement/): Recruitment privacy statement for Quantoom Biosciences candidates—how applicant personal data is collected, used, and protected during hiring in compliance with GDPR.
- [Satisfaction survey](https://quantoom.com/satisfaction-survey/): Post–field service satisfaction survey for Quantoom Biosciences customers to share feedback on installation, training, maintenance, and support experiences.
- [Technical Troubleshooting Form](https://quantoom.com/troubleshooting/): Technical troubleshooting form for Quantoom Ntensify® and Ncapsulate® equipment. Submit an issue and the customer service team will respond promptly.

## News

- [Bio Farma Selects Quantoom Biosciences’ Ntensify® RNA Production Platform to Accelerate Indonesia’s mRNA Vaccine Development](https://quantoom.com/news/bio-farma-selects-quantoom-biosciences-ntensify-rna-production-platform-to-accelerate-indonesias-mrna-vaccine-development/): Bio Farma has selected Quantoom Biosciences’ Ntensify® RNA production platform to support Indonesia’s mRNA vaccine programs, after a first production run validated high-quality RNA output.
- [Quantoom Biosciences’ Ntensify® Technology Supports Progress Toward Brazil’s First Homegrown mRNA Vaccine in Clinical Trials](https://quantoom.com/news/quantoom-biosciences-ntensify-technology-supports-progress-toward-brazils-first-homegrown-mrna-vaccine-in-clinical-trials/): Anvisa has authorized the start of clinical trials for Brazil’s first mRNA vaccine, developed on Bio-Manguinhos/Fiocruz’s national mRNA platform and supported by Quantoom Biosciences’ Ntensify® technology for RNA production and purification.
- [Quantoom Biosciences and Inside Therapeutics join forces to streamline the RNA-to-LNP workflow for researchers](https://quantoom.com/news/quantoom-biosciences-and-inside-therapeutics-join-forces-to-streamline-the-rna-to-lnp-workflow-for-researchers/): Quantoom Biosciences and Inside Therapeutics announce a commercial collaboration connecting the Ntensify® micro and mini benchtop systems with the TAMARA LNP formulation platform, giving researchers a more integrated path from RNA production to formulated product.
- [Quantoom Biosciences and Labscoop Announce Sales & Fulfillment Partnership to Expand North American Access to RNA Solutions.](https://quantoom.com/news/quantoom-biosciences-and-labscoop-announce-sales-fulfillment-partnership-to-expand-north-american-access-to-rna-solutions/): Quantoom Biosciences partners with Labscoop to expand North American access to RNA solutions via the Labscoop Marketplace and Fulfillment by Labscoop (FBL).
- [Quantoom Biosciences and Enparis Bio announce collaboration agreement to expand accessibility of its N-Force toolbox to the Indian life-science and bio-pharma industry.](https://quantoom.com/news/quantoom-biosciences-and-enparis-bio-announce-collaboration-agreement-to-expand-accessibility-of-its-n-force-toolbox-to-the-indian-life-scie/): Quantoom Biosciences and Enparis Bio (India) announce a strategic partnership to accelerate access to the N-Force platform across India's vaccine, biotech and life-science sectors.
- [Quantoom and Nucelion Therapeutics to Expand RNA capacity in India](https://quantoom.com/news/quantoom-and-nucelion-therapeutics-to-expand-rna-capacity-in-india/): Quantoom and Nucelion Therapeutics signed an MoU to explore a preferred RNA CDMO partnership in India, expanding N-Force platform access across human therapeutics and animal health.
- [Quantoom Biosciences and Chemopharm to collaborate on Malaysian distribution for Ntensify® mano and Ntensify® micro](https://quantoom.com/news/quantoom-biosciences-and-chemopharm-to-collaborate-on-malaysian-distribution-for-ntensify-mano-and-ntensify-micro/): Nivelles, Belgium / Kuala Lumpur, Malaysia — March 25, 2026 — Quantoom Biosciences, a full-stack RNA partner providing turnkey solutions for mRNA- and saRNA-based vaccines and therapeutics, today announced a distribution
- [Quantoom Biosciences Partners with Europa Biosite to Expand Access to Rapid RNA Production Technologies Across Europe](https://quantoom.com/news/quantoom-biosciences-partners-with-europa-biosite-to-expand-access-to-rapid-rna-production-technologies-across-europe/): Nivelles, Belgium — March 17, 2026 — Quantoom Biosciences today announced a new distribution partnership with Europa Biosite, a leading and fast-growing European life-science distributor. The agreement expands access to
- [Quantoom Biosciences and Skybioscience to collaborate on South-Korean distribution for Ntensify® mano and Ntensify® micro](https://quantoom.com/news/quantoom-biosciences-and-skybiosciences-to-collaborate-on-south-korean-distribution-for-ntensify-mano-and-ntensify-micro/): Quantoom Biosciences and Skybioscienc to collaborate on South-Korean distribution for Ntensify® mano and Ntensify® micro Nivelles [Nivelles, Belgium] / [Incheon, South-Korea] — Mar 12, 2026 — Quantoom Biosciences, a full-stack RNA partner
- [Quantoom Biosciences Appoints Soter Bio as Exclusive North America RNA CDMO for RUO and GMP Manufacturing](https://quantoom.com/news/quantoom-biosciences-appoints-soter-bio-as-exclusive-north-america-rna-cdmo-for-ruo-and-gmp-manufacturing/): Nivelles, Belgium, and Houston, Texas — February 9, 2026 Quantoom Biosciences, a leader in integrated RNA-LNP manufacturing technologies, today announced Soter Bio as its exclusive RNA Contract Development and Manufacturing
- [Afrigen Biologics Complete First Technical Production Run of mRNA Vaccine Against Rift Valley Fever with Quantoom Biosciences Ntensify® technology](https://quantoom.com/news/afrigen-biologics-complete-first-technical-production-run-of-mrna-vaccine-against-rift-valley-fever-with-quantoom-biosciences-ntensify-technology/): Cape Town, South Africa & Brussels, Belgium— December 12th, 2025 Afrigen Biologics and Quantoom Biosciences today announced the successful completion of a technical production run (800ml IVT) for an mRNA-based
- [University of Western Australia’s RNA Innovation Foundry Selects Quantoom Biosciences’ Ntensify® mini for Advanced RNA Research and Technology](https://quantoom.com/news/university-of-western-australias-rna-innovation-foundry-selects-quantoom-biosciences-ntensify-mini-for-advanced-rna-research-and-technology/): Perth, Australia & Nivelles, Belgium – December 3, 2025 Quantoom Biosciences today announced the adoption of the Ntensify® mini platform by The University of Western Australia’s (UWA) RNA Innovation Foundry
- [Quantoom Biosciences Signs Research License and Supply Agreement with Leading Global Cancer Center for mRNA Formulation Technology in Personalized Cancer Therapeutics](https://quantoom.com/news/quantoom-biosciences-signs-research-license-and-supply-agreement-with-leading-global-cancer-center-for-mrna-formulation-technology-in-personalized-cancer-therapeutics/): Nivelles, Belgium — September 25, 2025 Memorial Sloan Kettering Cancer Center (MSK), one of the world’s leading institutions for cancer treatment, research, and education, and Quantoom Biosciences, a full-stack RNA
- [VaxThera and Quantoom Biosciences Achieve Breakthrough in Poultry Vaccination Against Highly Pathogenic Avian Influenza (HPAI) Using Quantoom's N-Force Toolbox for saRNA](https://quantoom.com/news/vaxthera-and-quantoom-biosciences-achieve-breakthrough-in-poultry-vaccination-against-highly-pathogenic-avian-influenza-hpai-using-sarna-quantooms-n-force-toolbox/): Medellín, Colombia and Nivelles, Belgium – June 23, 2025 VaxThera, a biotechnology company that produce vaccines and biologics, and Quantoom Biosciences, a full-stack RNA partner for mRNA- and saRNA-based vaccines
- [TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology](https://quantoom.com/news/trilink-biotechnologies-and-quantoom-biosciences-sign-license-and-supply-agreement-for-cleancap-mrna-capping-technology/): Quantoom’s customers can now access TriLink’s CleanCap mRNA capping technology; Agreement supports future expansion of essential therapeutics & vaccines in developing countries & regions SAN DIEGO (June 3, 2025) TriLink
- [Inventprise Selects Quantoom Biosciences' Ntensify® Production Technology to Advance mRNA Vaccine Development](https://quantoom.com/news/inventprise-selects-quantoom-biosciences-ntensify-production-technology-to-advance-mrna-vaccine-development/): REDMOND, Wash., & NIVELLES, Belgium – May 15, 2025 Inventprise Inc., a clinical-stage vaccine invention company, announced today its selection of Quantoom Biosciences’ Ntensify midi system as the core technology
- [Quantoom Biosciences Announces Collaboration with University of Arizona Health Sciences on mRNA-Based Neoantigen Cancer Vaccine](https://quantoom.com/news/quantoom-biosciences-announces-collaboration-with-university-of-arizona-health-sciences-on-mrna-based-neoantigen-cancer-vaccine/): NIVELLES, Belgium – April 14, 2025 Quantoom Biosciences, a full-stack RNA partner for mRNA- and saRNA-based vaccines and therapeutics, is proud to announce a research collaboration with the University of
- [Quantoom Biosciences and DIANT Pharma Inc. Collaborate to Enhance mRNA Supply Chain Efficiency](https://quantoom.com/news/quantoom-biosciences-and-diant-pharma-inc-collaborate-to-enhance-mrna-supply-chain-efficiency/): Manchester, CT, USA & NIVELLES, Belgium – March 31, 2025 Quantoom Biosciences and DIANT Pharma Inc. are proud to announce a strategic collaboration to advance the supply chain for messenger
- [CAPTIVATE Project Update](https://quantoom.com/news/captivate-project-update/): March 2025 At the end of February, CAPTIVATE-EU held its annual meeting in Barcelona! Scientists Youlia Serikova and Erica Pasini took a moment after the session to share their key
- [The Pirbright Institute Adopts Quantoom Biosciences’ Ntensify® mini to Advance mRNA Vaccine Research for Livestock Diseases](https://quantoom.com/news/the-pirbright-institute-adopts-quantoom-biosciences-ntensify-mini-to-advance-mrna-vaccine-research-for-livestock-diseases/): Pirbright, UK & Nivelles, Belgium – Thursday, March 13, 2025 The Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM), part of The Pirbright Institute, a world-leading center for the research
- [India and Belgium Unite to Advance RNA-Based Vaccines: MoU Signed Between Techinvention and Quantoom Biosciences, in the presence of Her Royal Highness Princess Astrid of Belgium during the Belgian Economic Mission to India](https://quantoom.com/news/india-and-belgium-unite-to-advance-rna-based-vaccines-mou-signed-between-techinvention-and-quantoom-biosciences-in-the-presence-of-her-royal-highness-princess-astrid-of-belgium-during-the-belgian-ec/): Wednesday, March 5, 2025 TechInvention Lifecare Pvt. Ltd. (TechInvention) is proud to announce a strategic collaboration with Belgium-based Quantoom Biosciences (Quantoom). The Memorandum of Understanding (MoU) was formally signed during
- [Africa and Europe Join Forces to Revolutionize RNA-based Vaccines and Therapeutics Production: MoU Signed Between EVA Pharma, DNA Script, Quantoom Biosciences](https://quantoom.com/news/africa-and-europe-join-forces-to-revolutionize-rna-based-vaccines-and-therapeutics-production-mou-signed-between-eva-pharma-dna-script-quantoom-biosciences/): Cairo, Egypt – February 5, 2025 – Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a Memorandum of Understanding today, on the sidelines of the 2nd
- [Belgium and Brazil Unite to Advance RNA-Based Therapies: MoU Signed Between Bio-Manguinhos/Fiocruz, Quantoom Biosciences, and Univercells in the presence of Her Royal Highness Princess Astrid of Belgium during the Belgian Economic Mission to Brazil](https://quantoom.com/news/belgium-and-brazil-unite-to-advance-rna-based-therapies-mou-signed-between-bio-manguinhos-fiocruz-quantoom-biosciences-and-univercells-in-the-presence-of-her-royal-highness-princess-astrid-of-belgi/): Rio de Janeiro, Brazil – November 29, 2024 – During the Belgian Economic Mission to Brazil, a historic Memorandum of Understanding (MoU) was signed between the Brazilian Oswaldo Cruz Foundation
- [ST Pharm and Quantoom Biosciences Announce a First Supply Agreement of SmartCap® under Extended Collaboration to Advance RNA Manufacturing](https://quantoom.com/news/st-pharm-and-quantoom-biosciences-announce-a-first-supply-agreement-of-smartcap-under-extended-collaboration-to-advance-rna-manufacturing/): ST Pharm, a leading technology-driven RNA CDMO, and Quantoom Biosciences (also referred as “Quantoom”), a specialized RNA technology platform developer, today announced an extended collaboration to accelerate the development and
- [Quantoom Biosciences and Tiamat Sciences Announce Strategic Partnership to Revolutionize mRNA Production](https://quantoom.com/news/quantoom-biosciences-and-tiamat-sciences-announce-strategic-partnership-to-revolutionize-mrna-production/): DURHAM, North Carolina – Quantoom Biosciences S.A. (“Quantoom”), part of Univercells S.A., focused on mRNA production technologies for vaccines and therapeutics, and Tiamat Sciences, a plant-based platform and product life
- [Quantoom Biosciences Launches Ntensify® mano: A Groundbreaking kit for Rapid and Scalable mRNA Production](https://quantoom.com/news/quantoom-biosciences-launches-ntensify-mano-a-groundbreaking-kit-for-rapid-and-scalable-mrna-production/): Nivelles, Belgium – Quantoom Biosciences S.A. (“Quantoom”), a subsidiary of Univercells S.A., proudly announces the extension of the Ntensify® product line with the launch of Ntensify® mano, an mRNA kit
- [Quantoom Biosciences’ Ntensify® midi System Adopted by Bio-Manguinhos/Fiocruz Laboratory for Future Groundbreaking mRNA Vaccine Production in Latin America](https://quantoom.com/news/quantoom-biosciences-ntensify-midi-system-adopted-by-bio-manguinhos-fiocruz-laboratory-for-future-groundbreaking-mrna-vaccine-production-in-latin-america/): Quantoom Biosciences S.A. (“Quantoom”), part of Univercells S.A. is proud to announce its significant collaboration with the Institute of Technology on Immunobiologicals (Bio-Manguinhos/Fiocruz), Brazil’s leading public health institute and vaccine
- [Quantoom Biosciences Prepares for the Implementation of the Ntensify® midi System by Afrigen Biologics’ in their GMP Facility, Paving the Way for African-Owned mRNA Vaccine Production](https://quantoom.com/news/quantoom-biosciences-prepares-for-the-implementation-of-the-ntensify-midi-system-by-afrigen-biologics-in-their-gmp-facility-paving-the-way-for-african-owned-mrna-vaccine-production/): The Ntensify® Midi System Sets the Stage for Equitable Vaccine Access Quantoom Biosciences S.A. (“Quantoom”), a Univercells company, proudly announces the implementation of its first Ntensify® Midi system for mRNA
- [Quantoom Biosciences Collaborates with Stevanato Group to Elevate mRNA production with Nfinity™ Platform](https://quantoom.com/news/quantoom-biosciences-collaborates-with-stevanato-group-to-elevate-mrna-production-with-nfinity-platform/): Quantoom Biosciences (‘Quantoom’) is thrilled to announce a new collaboration with Stevanato Group, a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life science industries,
- [Quantoom Biosciences expands its offerings with Nplify, a high-quality linear DNA service for mRNA synthesis](https://quantoom.com/news/quantoom-biosciences-expands-its-offerings-with-nplify-a-high-quality-linear-dna-service-for-mrna-synthesis/): Quantoom Biosciences S.A. (“Quantoom”), a Univercells company, is proud to unveil the latest addition to its offering: a service for DNA amplification for use in mRNA applications.

## Events

- [AMM Ascent](https://quantoom.com/events/#event-amm-ascent-coronado-2026): Upcoming. 28–30 Oct 2026, Coronado, United States. Team: Emilie Viey. Meet Emilie Viey in Coronado to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [BIO-Europe](https://quantoom.com/events/#event-bio-europe-cologne-2026): Upcoming. 9–11 Nov 2026, Cologne, Germany. Team: Guillaume Roelandts. Meet Guillaume Roelandts in Cologne to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [RNA-based Therapeutics](https://quantoom.com/events/#event-rna-therapeutics-korea-2026): Upcoming. 18–20 Nov 2026, Seoul, South Korea. Team: Wen Hong Toh. Meet Wen Hong Toh in Seoul to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [Belgian economic mission in KSA](https://quantoom.com/events/#event-awex-ksa-2026): Upcoming. 21–26 Nov 2026, Riyadh, Saudi Arabia. Team: Maria Davila-Saignol, Jose Castillo, PhD. Meet our team in Riyadh to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [Congrès annuel de la Société Française de Nanomédecine](https://quantoom.com/events/#event-sfnano-paris-dec-2026): Upcoming. 30 Nov 2026 – 2 Dec 2026, Paris, France. Team: Didier Argentin. Meet Didier Argentin in Paris to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [3rd mRNA & CGT: CMC, PD & Manufacturing](https://quantoom.com/events/#event-mrna-cgt-munich-2026): Upcoming. 3–4 Dec 2026, Munich, Germany. Team: Didier Argentin. Meet Didier Argentin in Munich to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [ESMO Asia](https://quantoom.com/events/#event-esmo-singapore-2026): Upcoming. 4–6 Dec 2026, Singapore, Singapore. Team: Wen Hong Toh. Meet Wen Hong Toh in Singapore to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [BioFIT](https://quantoom.com/events/#event-biofit-marseille-2026): Upcoming. 10–11 Dec 2026, Marseille, France. Team: Didier Argentin, Hilde Vrancken, PhD. Meet Didier Argentin and Dr Hilde Vrancken in Marseille to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [I4ID 2026](https://quantoom.com/events/#event-i4id-lyon-2026): Past. 22–23 Oct 2026, Lyon, France. Team: Didier Argentin, Jose Castillo, PhD. Meet our team in Lyon to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [Schlieren Zurich](https://quantoom.com/events/#event-schlieren-zurich-2026): Past. 21–22 Oct 2026, Schlieren, Zurich, Switzerland. Team: Ashiqul Haque, PhD. Meet Ashiqul Haque in Zurich to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [AusBiotech](https://quantoom.com/events/#event-ausbiotech-2026): Past. 19–23 Oct 2026, Melbourne, Australia. Team: Wen Hong Toh. Meet Wen Hong Toh in Melbourne to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [World Vaccine Congress Europe](https://quantoom.com/events/#event-world-vaccine-amsterdam-2026): Past. 19–21 Oct 2026, Amsterdam, Netherlands. Team: Didier Argentin, Maria Davila-Saignol, Hilde Vrancken, PhD. Meet our team in Amsterdam to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [ISV Antwerp](https://quantoom.com/events/#event-isv-antwerp-2026): Past. 12–14 Oct 2026, Antwerp, Belgium. Team: Maria Davila-Saignol, Ashiqul Haque, PhD. Meet our team in Antwerp to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [Dutch Medicine Days](https://quantoom.com/events/#event-dutch-medicine-days-2026): Past. 7–8 Oct 2026, Leiden, Netherlands. Team: Emilie Viey. Meet Emilie Viey in Leiden to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [Fraunhofer IEE](https://quantoom.com/events/#event-fraunhofer-hannover-2026): Past. 22–23 Sept 2026, Hannover, Germany. Team: Didier Argentin. Meet Didier Argentin in Hannover to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [DCVMN International](https://quantoom.com/events/#event-dcvmn-beijing-2026): Past. 22–24 Sept 2026, Beijing, China. Team: Jose Castillo, PhD, Maria Davila-Saignol. Meet Jose Castillo and Maria Davila in Beijing to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [Cell & Gene Therapy Summit](https://quantoom.com/events/#event-cgt-summit-boston-2026): Past. 22–25 Sept 2026, Boston, United States. Team: James Timmins. Meet James Timmins in Boston to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [3rd RNA Horizons Conference](https://quantoom.com/events/#event-rna-horizons-munich-2026): Past. 16–18 Sept 2026, Munich, Germany. Team: Ashiqul Haque, PhD, Didier Argentin. Meet Quantoom in Munich to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [CPI meeting](https://quantoom.com/events/#event-cpi-london-2026): Past. 15–16 Sept 2026, London, United Kingdom. Team: Guillaume Roelandts, Youlia Serikova, PhD. Meet our team in London to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [RNA World 2026](https://quantoom.com/events/#event-rna-world-shanghai-2026): Past. 10–11 Sept 2026, Shanghai, China. Team: Wen Hong Toh. Meet Wen Hong Toh in Shanghai to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [CAR T Day](https://quantoom.com/events/#event-cart-day-lille-2026): Past. 10–11 Sept 2026, Lille, France. Team: Didier Argentin. Meet Didier Argentin in Lille to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [UKSEA VAX HUB](https://quantoom.com/events/#event-uksea-vax-hub-2026): Past. 9–11 Sept 2026, Sarawak, Malaysia. Team: Maria Davila-Saignol. Meet Maria Davila in Sarawak, Malaysia, to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [RNA Leaders APAC](https://quantoom.com/events/#event-rna-leaders-apac-2026): Past. 1–2 Sept 2026, Singapore, Singapore. Team: Wen Hong Toh. Meet Wen Hong Toh in Singapore to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [KC Animal Health Corridor](https://quantoom.com/events/#event-kc-animal-health-2026): Past. 31 Aug 2026 – 1 Sept 2026, Kansas City, United States. Team: Jose Castillo, PhD, Hilde Vrancken, PhD. Meet our team in Kansas to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [India Vaccine Leaders Conclave](https://quantoom.com/events/#event-india-vaccine-pune-2026): Past. 20–21 Aug 2026, Hyatt, Pune, India. Team: Rachana Talwar. Meet Rachana Talwar in Pune to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [Future Biotech Expo](https://quantoom.com/events/#event-future-biotech-houston-2026): Past. 19–20 Aug 2026, Houston, United States. Team: James Timmins. Meet James Timmins in Houston to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [Disease X workshop](https://quantoom.com/events/#event-disease-x-london-2026): Past. 24 Jul 2026, London, United Kingdom. Team: Hala Audi. Hala Audi joined Session 3 on decentralised, automated RNA/LNP platforms: faster response, more autonomy, and more equitable access to novel vaccines — with HE Mr Jeroen Cooreman and Dr Bassam Hallis (UKHSA).
- [mRNA Conference 2026](https://quantoom.com/events/#event-mrna-conference-frankfurt-2026): Past. 22–23 Jul 2026, Frankfurt, Germany. Team: Emilie Viey, Didier Argentin. Meet Emilie Viey and Didier Argentin in Frankfurt to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [Cell & Gene Therapy World Asia 2026](https://quantoom.com/events/#event-cgt-world-asia-2026): Past. 30 Jun 2026 – 1 Jul 2026, Singapore, Singapore. Team: Wen Hong Toh. Meet Wen Hong Toh in Singapore to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [NecstGen](https://quantoom.com/events/#event-necstgen-leiden-2026): Past. 30 Jun 2026, Leiden, Netherlands. Team: Emilie Viey, Didier Argentin. Meet Emilie Viey and Didier Argentin in Leiden to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [PSCC](https://quantoom.com/events/#event-pscc-paris-june-2026): Past. 24 Jun 2026, Paris, France. Team: Emilie Viey. Meet Emilie Viey in Paris to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [BIO International Convention](https://quantoom.com/events/#event-bio-international-sandiego-2026): Past. 22–25 Jun 2026, San Diego, United States. Team: Guillaume Roelandts, Hala Audi. Meet our team in San Diego to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [GenoTher Gene Therapy Biocluster](https://quantoom.com/events/#event-genother-paris-2026): Past. 17–18 Jun 2026, Paris, France. Team: Didier Argentin. Meet Didier Argentin in Paris to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [Alliance for mRNA Medicines](https://quantoom.com/events/#event-amm-philadelphia-2026): Past. 3 Jun 2026, Philadelphia, United States. Team: James Timmins. Meet James Timmins in Philadelphia to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [ICGT](https://quantoom.com/events/#event-icgt-paris-2026): Past. 27–28 May 2026, Paris, France. Team: Didier Argentin. Meet Didier Argentin in Paris to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [NAti Congress](https://quantoom.com/events/#event-nati-singapore-2026): Past. 19 May 2026, Singapore, Singapore. Team: Wen Hong Toh. Meet Wen Hong Toh in Singapore to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [DIAH Conference](https://quantoom.com/events/#event-diah-bruges-2026): Past. 19–21 May 2026, Bruges, Belgium. Team: Didier Argentin, Hilde Vrancken, PhD, Ashiqul Haque, PhD. Meet our team in Bruges to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [Swiss Biotech Day](https://quantoom.com/events/#event-swiss-biotech-basel-2026): Past. 4–5 May 2026, Basel, Switzerland. Team: Didier Argentin. Meet Didier Argentin in Basel to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [SFNan](https://quantoom.com/events/#event-sfnan-paris-2026): Past. 10 Apr 2026, Paris, France. Team: Didier Argentin, Hala Audi. Meet our team in Paris to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [Animal AgTech Innovation Summit](https://quantoom.com/events/#event-animal-agtech-fortworth-2026): Past. 8–9 Apr 2026, Fort Worth, United States. Team: Hilde Vrancken, PhD. Meet Dr Hilde Vrancken in Fort Worth to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [World Vaccine Congress Washington](https://quantoom.com/events/#event-world-vaccine-washington-2026): Past. 31 Mar 2026 – 2 Apr 2026, Washington, D.C., United States · Booth #329. Team: Jose Castillo, PhD, James Timmins. Meet us in Washington at booth #329 and discover our N-Force toolbox — a suite of technologies designed to fast-track your RNA development, from design to delivery.
- [Next-generation mRNA vaccines against complex pathogens](https://quantoom.com/events/#event-vib-leuven-2026): Past. 25–26 Mar 2026, Leuven, Belgium. Team: Youlia Serikova, PhD, Ashiqul Haque, PhD, Didier Argentin. Meet our team in Leuven to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [BIO-Europe Spring & LSX World Congress](https://quantoom.com/events/#event-bio-europe-lsx-lisbon-2026): Past. 23–26 Mar 2026, Lisbon, Portugal. Team: Hala Audi. Meet Hala Audi in Lisbon to find out more about the N-Force toolbox — a suite of technologies designed to fast-track your RNA development, from design to delivery.
- [Buzz4Bio](https://quantoom.com/events/#event-buzz4bio-charleroi-2026): Past. 11 Mar 2026, Charleroi, Belgium. Team: Jose Castillo, PhD. Meet Jose Castillo in Charleroi to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [Vaccine Innovation Forum World](https://quantoom.com/events/#event-vif-shanghai-2026): Past. 11–14 Mar 2026, Shanghai, China. Team: Jose Castillo, PhD, Maria Davila-Saignol, Wen Hong Toh. Meet our team in Shanghai to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [AHNTI](https://quantoom.com/events/#event-ahnti-london-2026): Past. 2–4 Mar 2026, London, United Kingdom. Team: Didier Argentin, Hilde Vrancken, PhD. Meet our team in London to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [BIO Asia 2026](https://quantoom.com/events/#event-bio-asia-hyderabad-2026): Past. 17–18 Feb 2026, Hyderabad, India. Team: Jose Castillo, PhD. Meet Jose Castillo in Hyderabad to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.
- [PSCC](https://quantoom.com/events/#event-pscc-paris-2026): Past. 4 Feb 2026, Paris, France. Team: Guillaume Roelandts, Didier Argentin. Meet us in Paris to find out more about the N-Force toolbox, a suite of technologies designed to fast-track your RNA development, from design to delivery.
- [IPPE](https://quantoom.com/events/#event-ippe-atlanta-2026): Past. 27–29 Jan 2026, Atlanta, United States. Team: James Timmins. Meet James Timmins in Atlanta to discover our N-Force toolbox — an integrated suite of RNA technologies designed to accelerate your development journey, from sequence design to delivery.

## Topics

- mRNA and saRNA vaccines
- RNA therapeutics
- Personalized cancer vaccines
- Animal health RNA vaccines
- GMP and RUO manufacturing
- Synthetic biology

## Contact

- Website: https://quantoom.com
- LinkedIn: https://fr.linkedin.com/company/quantoom-biosciences
- YouTube: https://www.youtube.com/@quantoombiosciences

## Optional

- [Sitemap](https://quantoom.com/sitemap.xml)
- [Privacy statement](https://quantoom.com/privacy-statement/)
- [Cookies notice](https://quantoom.com/cookies-notice/)